Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Krystal Biotech (KRYS) Asset Utilization Ratio (2021 - 2025)

Krystal Biotech (KRYS) has disclosed Asset Utilization Ratio for 4 consecutive years, with 0.3 as the latest value for Q4 2025.

  • Quarterly Asset Utilization Ratio rose 6.05% to 0.3 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.3 through Dec 2025, up 6.05% year-over-year, with the annual reading at 0.33 for FY2025, 5.05% up from the prior year.
  • Asset Utilization Ratio hit 0.3 in Q4 2025 for Krystal Biotech, down from 0.31 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.32 in Q2 2025 to a low of 0.0 in Q4 2021.
  • Historically, Asset Utilization Ratio has averaged 0.2 across 4 years, with a median of 0.25 in 2024.
  • Biggest five-year swings in Asset Utilization Ratio: soared 2090.57% in 2024 and later increased 6.05% in 2025.
  • Year by year, Asset Utilization Ratio stood at 0.0 in 2021, then skyrocketed by 2375.81% to 0.06 in 2023, then skyrocketed by 352.25% to 0.29 in 2024, then rose by 6.05% to 0.3 in 2025.
  • Business Quant data shows Asset Utilization Ratio for KRYS at 0.3 in Q4 2025, 0.31 in Q3 2025, and 0.32 in Q2 2025.